
Results
17
Large pharmaceutical stocks to buy with strong dividend features.
17 companies
Abbott India
Market Cap: ₹605.3b
Operates as a pharmaceutical company in India.
500488
₹28,486.35
7D
-0.5%
1Y
-4.9%
Cipla
Market Cap: ₹1.2t
Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
CIPLA
₹1,500.90
7D
0.3%
1Y
-2.4%
Dr. Reddy's Laboratories
Market Cap: ₹1.1t
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,253.60
7D
-1.0%
1Y
-8.7%
Alkem Laboratories
Market Cap: ₹658.4b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹5,463.50
7D
-1.8%
1Y
-2.1%
Sun Pharmaceutical Industries
Market Cap: ₹4.1t
A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.
SUNPHARMA
₹1,721.10
7D
-0.9%
1Y
-8.4%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹285.2b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,816.30
7D
0.1%
1Y
-2.5%
Lupin
Market Cap: ₹964.8b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹2,103.30
7D
-0.3%
1Y
-12.2%
Zydus Lifesciences
Market Cap: ₹920.8b
Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.
ZYDUSLIFE
₹915.05
7D
-0.3%
1Y
-7.6%
Glenmark Pharmaceuticals
Market Cap: ₹574.3b
Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.
GLENMARK
₹2,026.20
7D
0.3%
1Y
23.6%
Ipca Laboratories
Market Cap: ₹354.7b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.
IPCALAB
₹1,398.20
7D
-1.2%
1Y
-19.8%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹418.6b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,455.25
7D
-1.2%
1Y
10.5%
Torrent Pharmaceuticals
Market Cap: ₹1.3t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,847.75
7D
0.4%
1Y
11.7%
Pfizer
Market Cap: ₹224.9b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,915.80
7D
-2.4%
1Y
-7.7%
Aurobindo Pharma
Market Cap: ₹687.1b
A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.
AUROPHARMA
₹1,193.00
7D
-1.5%
1Y
-11.6%
Eris Lifesciences
Market Cap: ₹205.1b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
ERIS
₹1,501.40
7D
-2.8%
1Y
13.6%
Ajanta Pharma
Market Cap: ₹367.0b
A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.
AJANTPHARM
₹2,938.40
7D
7.5%
1Y
-1.3%
Gland Pharma
Market Cap: ₹282.6b
Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
GLAND
₹1,715.10
7D
3.9%
1Y
-6.9%